Janone Inc. (NASDAQ:ALTS - Get Free Report) saw a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 331,000 shares, an increase of 40.9% from the February 13th total of 235,000 shares. Based on an average daily trading volume, of 236,100 shares, the short-interest ratio is currently 1.4 days. Currently, 2.4% of the company's stock are short sold.
Janone Trading Up 7.3 %
Shares of Janone stock traded up $0.32 during trading hours on Thursday, reaching $4.72. 167,729 shares of the company's stock were exchanged, compared to its average volume of 237,564. The company has a 50 day moving average of $5.71 and a two-hundred day moving average of $3.79. Janone has a fifty-two week low of $1.29 and a fifty-two week high of $7.75. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 1.96.
Janone Company Profile
(
Get Free Report)
ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments.
See Also
Before you consider Janone, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Janone wasn't on the list.
While Janone currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.